Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

NCT06375044 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Multiple Myeloma

Interventions

DRUG: SIM0500

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.

Collaborators

[object Object]